Stephanie Daveson

Clayton Utz
Partner Brisbane

Stephanie has over 25 years' experience advising on private and public mergers and acquisitions, restructures and demergers, equity capital market transactions, governance and Listing Rule and Corporations Law compliance. 

Stephanie has a reputation for commercial and strategic advice, effective transaction execution and excellent legal project management skills in complex commercial transactions. Clients testify to her ""ability to deliver reliable, outstanding results time and time again, regardless of the time pressures. Her advice demonstrates her aptitude to think commercially and with the precision and clarity that is second to none, and in our view sets her above the pack for other legal providers in this market."" (Client quote, 2018)

This year Stephanie was recognised as Brisbane Corporate Lawyer of the Year and Lawyer of the Year - Capital Markets and as a Best Lawyer in Mergers and Acquisitions since 2013 in the peer reviewed “Best Lawyers” publication. Having recently been involved as a non-executive director of the ASX 300 company while it was the subject of a hostile takeover bid and as a former member of the Takeovers Panel, Stephanie is unique in that she has experience in acting as legal adviser, a regulator and a non-executive director in M&A transactions.

Stephanie is National Practice Group Leader – Corporate/M&A, Capital Markets.

Notable Work
  • Acquisition of ICON Cancer Care by QIC, GS PIA and others
  • Motorcycle Holdings acquisition of Australia's largest distributor of motorcycle accessories, Cassens
  • Vossloh acquisition of rail infrastructure company, Austrak
  • Healthia acquisition of 46 allied health businesses, including Allsports Physiotherapy, my FootDr and Extend Rehabilitation
  • RACQ acquisition of interest in TicketMates Australia
  • Aurizon divestment of its CRT bulk freight hauling business
  • Aurizon divestment of the Moorebank Intermodal Terminal
  • Magnitogorsk Iron and Steel Works OJSC takeover bid for Flinders Mines including successfully defending Takeover's Panel proceedings
  • Aurizon bid for Grail
  • QIC, Goldman Sachs, Pagoda acquisition of ICON Cancer Care
  • Weis sale of business to Unilever
  • Seymour Whyte defence of Watpac bid and sale to VINCI
  • Straits Resources demerger of its copper gold business from its coal business
  • Straits Resources sale of its coal business by scheme of arrangement
  • Straits Resources sale 60% of its international coal assets to PTT Group
  • Minemakers bid to acquire UCL Resources
  • Jupiters merger with TABCORP
  • Jupiters takeover of Breakwater Island Hotel & Casino
  • Jupiters takeover of AWA
  • AWA sale of totalisator operations to TAB
  • Healthia IPO
  • Smiles Inclusive IPO advising Lead Manager & Underwriter  
  • PWR Holdings $150m IPO
  • Motorcycle Holdings $60m renounceable rights issue
  • Wagners IPO advising Lead Manager and Underwriter
  • Stanmore Coal $36m placement
  • Arrow Energy IPO advising Lead Manager and Underwriter
  • Stanmore Coal $15m rights issue
  • Retail Food Group IPO advising Lead Manager and Underwriter
  • Straits Metal IPO
  • Renison Consolidated Mines IPO advising Lead Manager and Underwriter
  • Virtus Health IPO advising Doctors and management
  • Capilano Honey IPO advising Lead Manager and Underwritier
  • Watpac $73m placement and SPP
  • Queensland Gas Company IPO advising Lead Manager and Underwriter
  • Straits Resources $60m renounceable rights issue
  • Penrice Soda IPO advising Lead Manager and Underwriter
  • Straits Resources $50m placement and SPP
  • Mastermyne Limited IPO advising Lead Manager and Underwriter
  • Straits Asia Resources $2.1b secondary listing on ASX
  • Sedgman IPO advising Lead Manager and Underwriter
  • Stanmore Coal rights issues, placements & SPP
  • Straits Resources renounceable rights issue, institutional placement and SPP
  • Watpac $40m rights issue
  • Straits Asia Resources $2.1 billion secondary listing on ASX
  • Jupiters $190m reset preference share issue 
  • AWA sale of totalisator operations to TAB    
  • Healthia (allied health services) IPO
  • Smiles Inclusive (dentistry) IPO advising Lead Manager & Underwriter
  • ICON Cancer Care acquisition by QIC, GS PIA and Pagoda Investments ($1b+)
  • QScan incentive arrangements for senior executives
  • Valient acquisition of Australian operations of MP Biomedicals
  • Queensland Fertility Group sale to Virtus Health, owned by Quadrant Private Equity
  • Virtus Health advised Doctors and management on IPO
  • ImpediMed development fund raising from US and Australian investors
  • Alchemia demerger of drug discovery business (to be listed on NASDAQ) from pharmaceutical business (listed on ASX)
  • ImpediMed IPO, rights issues, placements and share purchase plans ($56.2m)
  • Alchemia fundraising in US in conjunction with NASDAQ listing
  • ImpediMed demerger and redomicile of its cardiology company into the US
  • Panbio takeover by Inverness Medical Innovations
  • Arana Therapeutics takeover of Evogenix
  • Aranna Therapeutics takeover of Agenix
  • Alchemia reverse takeover of a NASDAQ listed company 
Find other people to support you